By Editor , 29 September 2026
Ozempic Dose Escalation Cuts Cardiovascular Risk 6% Versus Mounjaro Switch

Plainsboro, N.J. – – September 29, 2026 -- Novo Nordisk reported that adults with type 2 diabetes who escalated their semaglutide dose to 2 mg showed a statistically significant 6% lower risk of major adverse cardiovascular events (MACE) compared with patients who switched to tirzepatide, according to real-world data presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026 in Milan.

By Editor , 29 September 2026
Amcor Names Tom Long Chairman as Liebelt Retires After 13 Years

Zurich – September 29, 2026 -- Amcor (NYSE: AMCR, ASX: AMC) confirmed that Graeme Liebelt will step down as Chairman after nearly 13 years, with the Board electing Tom Long as his successor effective at the company's Nov. 11, 2026 annual meeting.

By Editor , 29 September 2026

Taipei – – September 29, 2026 -- ORing Industrial Networking, a Taiwan-based industrial networking specialist with 20 years of market experience, showcased its next-generation IRoN railway Ethernet switch portfolio at InnoTrans 2026.

By Editor , 29 September 2026

Espoo – September 29, 2026 -- Valmet Oyj's Board of Directors has confirmed that the second instalment of its 2025 dividend, EUR 0.67 per share, will be paid on October 7, 2026.

Shareholders on record October 1 qualify for payout

The dividend will go to shareholders registered in Valmet's shareholders' register held by Euroclear Finland Oy on the record date of October 1, 2026.

By Editor , 29 September 2026

Washington D.C. – September 29, 2026 -- Implantica AG launched its FDA-approved RefluxStop device in the U.S. market at the American Foregut Society (AFS) 2026 Annual Meeting, drawing an over-capacity crowd of more than 120 surgeons and gastroenterologists that forced organizers to turn away additional attendees.

By Editor , 29 September 2026
Arthex Biotech Names Ex-IVERIC bio CEO Glenn Sblendorio Chairman

Valencia – – September 29, 2026 -- Arthex Biotech has appointed Glenn Sblendorio, former CEO of IVERIC bio, as Chairman of its Board of Directors as the clinical-stage RNA therapeutics company advances its lead program ATX-01 through Phase I/IIa trials for myotonic dystrophy type 1 (DM1).

By Editor , 29 September 2026
Leopard Imaging Debuts 8 AI Perception Cameras at VISION 2026

Fremont, Calif. – September 29, 2026 -- Leopard Imaging will unveil eight new camera and AI perception platforms at VISION 2026, the machine vision trade show running October 6-8 in Stuttgart, Germany, at Hall 10, Booth 10G79.

Sirius Max combines Lumotive beam-steering with iToF depth sensing for long-range robotics perception

The compact RGB + depth platform supports programmable beam-steered illumination and embedded synchronization for software-defined 3D scanning in autonomous systems.